165 related articles for article (PubMed ID: 37974546)
21. Association between treatment of superficial bladder cancer and 10-year mortality in older adults with multiple chronic conditions.
Garg T; Young AJ; O'Keeffe-Rosetti M; McMullen CK; Nielsen ME; Kirchner HL; Murphy TE
Cancer; 2018 Dec; 124(23):4477-4485. PubMed ID: 30289971
[TBL] [Abstract][Full Text] [Related]
22. A prospective descriptive 1-year study in France of all BCG therapy dispensations for non-muscle-invasive bladder cancer.
Neuzillet Y; Leon P; Seisen T; Allory Y; Audenet F; Loriot Y; Masson-Lecomte A; Mejean A; Pradère B; Roumiguié M; Traxer O; Xylinas E; Fournier G; Roupret M
BJU Int; 2023 May; 131(5):611-616. PubMed ID: 36462164
[TBL] [Abstract][Full Text] [Related]
23. Prospective Assessment of Vesical Imaging Reporting and Data System (VI-RADS) and Its Clinical Impact on the Management of High-risk Non-muscle-invasive Bladder Cancer Patients Candidate for Repeated Transurethral Resection.
Del Giudice F; Barchetti G; De Berardinis E; Pecoraro M; Salvo V; Simone G; Sciarra A; Leonardo C; Gallucci M; Catalano C; Catto JWF; Panebianco V
Eur Urol; 2020 Jan; 77(1):101-109. PubMed ID: 31699526
[TBL] [Abstract][Full Text] [Related]
24. A 10-Item Frailty Index Based on a Comprehensive Geriatric Assessment (FI-CGA-10) in Older Adults with Cancer: Development and Construct Validation.
Nishijima TF; Shimokawa M; Esaki T; Morita M; Toh Y; Muss HB
Oncologist; 2021 Oct; 26(10):e1751-e1760. PubMed ID: 34216413
[TBL] [Abstract][Full Text] [Related]
25. Assessment of quality of life, information, and supportive care needs in patients with muscle and non-muscle invasive bladder cancer across the illness trajectory.
Chung J; Kulkarni GS; Morash R; Matthew A; Papadakos J; Breau RH; Guttman D; Bender J; Jones JM
Support Care Cancer; 2019 Oct; 27(10):3877-3885. PubMed ID: 30767131
[TBL] [Abstract][Full Text] [Related]
26. Frailty Index Developed From a Cancer-Specific Geriatric Assessment and the Association With Mortality Among Older Adults With Cancer.
Guerard EJ; Deal AM; Chang Y; Williams GR; Nyrop KA; Pergolotti M; Muss HB; Sanoff HK; Lund JL
J Natl Compr Canc Netw; 2017 Jul; 15(7):894-902. PubMed ID: 28687577
[No Abstract] [Full Text] [Related]
27. Quality of Life After Bladder Cancer: A Cross-sectional Survey of Patient-reported Outcomes.
Catto JWF; Downing A; Mason S; Wright P; Absolom K; Bottomley S; Hounsome L; Hussain S; Varughese M; Raw C; Kelly P; Glaser AW
Eur Urol; 2021 May; 79(5):621-632. PubMed ID: 33581875
[TBL] [Abstract][Full Text] [Related]
28. Comparison of standard vs. palliative management for bladder cancer in patients older than 85 years: multicenter study of 317 de novo tumors.
Carrion A; Huguet J; Ribal MJ; Domínguez A; Bonet X; Servián P; Mayordomo O; Ajami T; Picola N; Freixa R; Díaz F; Lozano F; Raventós C; Morote J
Urol Oncol; 2020 Feb; 38(2):40.e9-40.e15. PubMed ID: 31586544
[TBL] [Abstract][Full Text] [Related]
29. Urologic symptoms and burden of frailty and geriatric conditions in older men: the Aging Study of PyeongChang Rural Area.
Jang IY; Lee CK; Jung HW; Yu SS; Lee YS; Lee E; Kim DH
Clin Interv Aging; 2018; 13():297-304. PubMed ID: 29503533
[TBL] [Abstract][Full Text] [Related]
30. Adaptation and validation of a Spanish version of the treatment burden questionnaire in patients with multiple sclerosis.
Ysrraelit MC; Fiol MP; Peña FV; Vanotti S; Terrasa SA; Tran VT; Montori VM; Correale J
BMC Neurol; 2019 Aug; 19(1):209. PubMed ID: 31455235
[TBL] [Abstract][Full Text] [Related]
31. Association Between Symptom Burden and Physical Function in Older Patients with Cancer.
Pandya C; Magnuson A; Flannery M; Zittel J; Duberstein P; Loh KP; Ramsdale E; Gilmore N; Dale W; Mohile SG
J Am Geriatr Soc; 2019 May; 67(5):998-1004. PubMed ID: 30848838
[TBL] [Abstract][Full Text] [Related]
32. Comparing Survival Outcomes and Costs Associated With Radical Cystectomy and Trimodal Therapy for Older Adults With Muscle-Invasive Bladder Cancer.
Williams SB; Shan Y; Jazzar U; Mehta HB; Baillargeon JG; Huo J; Senagore AJ; Orihuela E; Tyler DS; Swanson TA; Kamat AM
JAMA Surg; 2018 Oct; 153(10):881-889. PubMed ID: 29955780
[TBL] [Abstract][Full Text] [Related]
33. A Systematic Review and Meta-analysis of Chemoablation for Non-muscle-invasive Bladder Cancer.
Yanagisawa T; Quhal F; Kawada T; Mostafaei H; Motlagh RS; Laukhtina E; Rajwa P; Deimling MV; Bianchi A; Pallauf M; Majdoub M; Pradere B; Moschini M; Karakiewicz PI; Teoh JY; Miki J; Kimura T; Shariat SF
Eur Urol Focus; 2023 May; 9(3):463-479. PubMed ID: 36517409
[TBL] [Abstract][Full Text] [Related]
34. Treatment of muscle invasive bladder cancer in the elderly: navigating the trade-offs of risk and benefit.
VanderWalde NA; Chi MT; Hurria A; Galsky MD; Nielsen ME
World J Urol; 2016 Jan; 34(1):3-11. PubMed ID: 26497825
[TBL] [Abstract][Full Text] [Related]
35. Analysing cause of death during follow-up for non-muscle-invasive bladder cancer: is there a role for watchful waiting?
Zhang Y; Nosseir M; Dyer J
Ann R Coll Surg Engl; 2024 Jan; 106(1):57-63. PubMed ID: 36239948
[TBL] [Abstract][Full Text] [Related]
36. The association between BCG treatment in patients with bladder cancer and subsequent risk of developing Alzheimer and other dementia.-A Swedish nationwide cohort study from 1997 to 2019.
Wang E; Hagberg O; Malmström PU
PLoS One; 2023; 18(12):e0292174. PubMed ID: 38096211
[TBL] [Abstract][Full Text] [Related]
37. Treatment and surveillance for non-muscle-invasive bladder cancer: a clinical practice guideline (2021 edition).
Jin YH; Zeng XT; Liu TZ; Bai ZM; Dou ZL; Ding DG; Fan ZL; Han P; Huang YR; Huang X; Li M; Li XD; Li YN; Li XH; Liang CZ; Liu JM; Ma HS; Qi J; Shi JQ; Wang J; Wang DL; Wang ZP; Wang YY; Wang YB; Wei Q; Xia HB; Xing JC; Yan SY; Zhang XP; Zheng GY; Xing NZ; He DL; Wang XH;
Mil Med Res; 2022 Aug; 9(1):44. PubMed ID: 35978389
[TBL] [Abstract][Full Text] [Related]
38. Prediction for recurrent non-muscle invasive bladder cancer.
Li K; Raveendran A; Xie G; Zhang Y; Wu H; Huang Z; Jia Z; Yang J
Cancer Biomark; 2023; 38(3):275-285. PubMed ID: 37661872
[TBL] [Abstract][Full Text] [Related]
39. Adherence to lifestyle recommendations after non-muscle invasive bladder cancer diagnosis and risk of recurrence.
van Zutphen M; Hof JP; Aben KK; Kampman E; Witjes JA; Kiemeney LA; Vrieling A
Am J Clin Nutr; 2023 Apr; 117(4):681-690. PubMed ID: 36781128
[TBL] [Abstract][Full Text] [Related]
40. Urine Cytology Rarely Escalates Clinical Management in the Surveillance of Non-muscle-Invasive Bladder Cancer.
Feiertag N; Barry E; Abramson M; Park JY; Kovac E; Aboumohamed A; Watts K; Sankin A
Clin Genitourin Cancer; 2023 Apr; 21(2):258-264. PubMed ID: 36621462
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
